Loading candles…
Novartis India Ltd. operates in the pharmaceutical industry in India, focusing on the trading and distribution of pharmaceutical products. Its product offerings include various pharmaceutical products and therapeutic solutions aimed at patients across the Indian market. The company functions as a subsidiary of the Swiss multinational Novartis AG, which holds a significant stake in the company. Novartis India Ltd. leverages the research and development capabilities of its global parent to support its operations in India.
This page is a live market overview for NOVARTIS INDIA LIMITED (NOVARTIND) on the NSE. As a listed security, NOVARTIS INDIA LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for NOVARTIND before placing trades on tick2trade.
As of the latest feed, NOVARTIND last traded at ₹1,609.6 on NSE, down ₹0.1 (0.01%) from the previous close of ₹1,609.7. Today's session range is ₹1,589.7 – ₹1,634.9, against a 52-week band of ₹950 – ₹1,780. Traded volume today stands at 12.03K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for NOVARTIND in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether NOVARTIND is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for NOVARTIS INDIA LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in NOVARTIND. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated NOVARTIND option chain page linked from this overview.
| Index Review | NSE indices rebalancing | 31 Mar 2026 |
| Expiry | Monthly F&O expiry | 30 Jan 2026 |
| Expiry | Monthly F&O expiry | 27 Feb 2026 |
| Holiday | Republic Day — market closed | 26 Jan 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.